Genesis Molecular AI

Genesis Molecular AI builds AI models for small molecule drug discovery and uses them to design drugs for its own pipeline and for pharmaceutical partners. Its platform, GEMS, generates candidate molecules and predicts their 3D binding structure, potency, selectivity, and drug-like properties before they are made in the lab, with chemists and AI agents deciding which to synthesize. The company addresses the cost and failure rate of trial-and-error drug discovery, in which chemists screen and optimize large numbers of molecules experimentally before finding one worth taking into clinical trials.